Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Mexico / NCT06553482
Starting soon Not applicable

FatMax Training on Metabolic and Epigenetic Parameters

NCT06553482 · tracked via the Priya Life Science Mexico tracker
Sponsor
Universidad Autonoma de Baja California
Phase
Not applicable
Started
2025-01-01
Last updated
2024-08-15

Condition(s) studied

Overweight and ObesityBody Weight Changes

Investigational drug(s) / intervention(s)

FatMAx training interventionFatMax and physical endurance exercise interventionControl

FatMAx training intervention: FatMax training program on a treadmill or stationary bicycle, whichever is more convenient for them

FatMax and physical endurance exercise intervention: FatMax training program on a treadmill or stationary bicycle, whichever is more convenient for them, with muscular endurance exercise

Control: No intervention pf physical activity

Study summary

Exercise is an essential pillar for the health of all individuals, as it contributes to physical, mental, and emotional well-being. Various international organizations, such as the World Health Organization, advocate for the integration of exercise into healthy lifestyles, recognizing its im-portance in disease prevention and improving quality of life. However, despite the general consensus on its value, there is no universal agreement on specific prescriptions for vulnerable groups, highlighting the need for personalized approaches that consider the unique characteristics and needs of each individual. It has been proposed that a moderate aerobic exercise training program could promote positive outcomes in individuals living with overweight and obesity, particularly with an emphasis on reducing injury risk, ensuring high adherence, and achieving favorable health changes. In this regard, the present protocol establishes the basis for a randomized clinical trial based on exercise prescription at the maximal fat oxidation rate in young individuals with overweight and obesity, with a duration of 16 weeks. Throughout the study, biochemical changes (cholesterol, glucose, triglycerides, and inflammatory markers), metabolic changes (de-termination of fat and carbohydrate utilization rates during rest and exercise), and epigenetic changes (focusing on microRNAs associated with adipogenesis, inflammation, and fat metabolism) will be monitored.

Eligibility

Sex
ALL
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Both genders * Daily energy expenditure \<4 METs * Body mass index ≥25 kg/m2 * Acceptance of informed consent Exclusion/elimination Criteria: * ≥100 ml of alcohol consumption per week * Consume a dietary supplement or pharmacological treatment * Have limitations to perform regular physical activity * Have a chronic non-communicable disease * Answer "yes" to any of the questions on the Physical Activity Readiness- Questionnaire for Everyone (PAR-Q+); which represents a health risk. * \<80% attendance at exercise sessions

Primary outcome measure(s)

  • Body composition change — 16 weeks
    Changes in body composition (fat mass and muscle mass) after the intervention

Trial sites (1)

FacilityCityRegionStatus
Medical and Psychology School Tijuana California

More Universidad Autonoma de Baja California trials in Mexico

Genetic Markers Associated With Capsaicinoid Supplementation Effects in Overweight and Obesity Active, not recruiting
Life Skills-Based Intervention on Substance Use Intention in Adolescents in Social Care Institutions Starting soon
3D-printed Ceromer Crowns Versus Stainless Steel in Posterior Primary Molars Starting soon
Psychological Intervention on Cold Executive Function and Academic Performance in University Women With Insomnia Starting soon
Insomnia´s Impact on DNA Stability, Cardio-metabolic Health and Lifestyle Behaviors Recruiting

Other trials for the same condition

Genetic Markers Associated With Capsaicinoid Supplementation Effects in Overweight and Obesity Active, not recruiting
Educational Intervention in the First 18 Months of Life to Prevent/Manage Obesity of Children After Gestational Diabetes Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06553482 on ClinicalTrials.gov ↗ ← All trials in Mexico